Background: Ivabradine is a novel specific heart rate (HR)-lowering agent that improves event-free survival in patients with heart failure (HF). Objectives: We aimed to evaluate the effect of ivabradine on time domain indices of heart rate variability (HRV) in patients with HF. Methods: Forty-eight patients with compensated HF of nonischemic origin were included. Ivabradine treatment was initiated according to the latest HF guidelines. For HRV analysis, 24-h Holter recording was obtained from each patient before and after 8 weeks of treatment with ivabradine. Results: The mean RR interval, standard deviation of all normal to normal RR intervals (SDNN), the standard deviation of 5-min mean RR intervals (SDANN), the mean of the standard...
AbstractBackgroundThe aim of this study was to investigate the effect of ivabradine on symptoms, qua...
Background Chronic heart failure is associated with high mortality and morbidity. Raised resting hea...
Chronic heart failure is associated with high mortality and morbidity. Raised resting heart rate is ...
Background: Ivabradine is a novel specific heart rate (HR)-lowering agent that improves event-free s...
Background: Heart rate (HR) reduction is of benefit in chronic heart failure (HF). The effect of hea...
Objectives: Ivabradine is a pharmacological agent used in patients with heart failure and sinus rhyt...
Background: The aim of this study was to investigate the effect of ivabradine on symptoms, quality o...
Aims Analysis of 24-h Holter recordings was a pre-specified substudy of SHIFT (Systolic Heart Failu...
WOS: 000392042800008PubMed: 28115808Background: The aim of our study was to evaluate in stable outpa...
Background: Heart rate (HR) reduction is associated with improved outcomes in patients with heart fa...
Objective: To compare mean heart rate reduction in Ivabradine and placebo group in left ventricular ...
Increased heart rate (HR) is associated with deleterious effects on several disease conditions. Chro...
peer reviewedBACKGROUND: Chronic heart failure is associated with high mortality and morbidity. Rais...
Aims This randomized, double-blind, placebo-controlled trial assessed whether heart rate (HR) reduct...
BACKGROUND: An elevated heart rate is an established marker of cardiovascular risk. Previous analys...
AbstractBackgroundThe aim of this study was to investigate the effect of ivabradine on symptoms, qua...
Background Chronic heart failure is associated with high mortality and morbidity. Raised resting hea...
Chronic heart failure is associated with high mortality and morbidity. Raised resting heart rate is ...
Background: Ivabradine is a novel specific heart rate (HR)-lowering agent that improves event-free s...
Background: Heart rate (HR) reduction is of benefit in chronic heart failure (HF). The effect of hea...
Objectives: Ivabradine is a pharmacological agent used in patients with heart failure and sinus rhyt...
Background: The aim of this study was to investigate the effect of ivabradine on symptoms, quality o...
Aims Analysis of 24-h Holter recordings was a pre-specified substudy of SHIFT (Systolic Heart Failu...
WOS: 000392042800008PubMed: 28115808Background: The aim of our study was to evaluate in stable outpa...
Background: Heart rate (HR) reduction is associated with improved outcomes in patients with heart fa...
Objective: To compare mean heart rate reduction in Ivabradine and placebo group in left ventricular ...
Increased heart rate (HR) is associated with deleterious effects on several disease conditions. Chro...
peer reviewedBACKGROUND: Chronic heart failure is associated with high mortality and morbidity. Rais...
Aims This randomized, double-blind, placebo-controlled trial assessed whether heart rate (HR) reduct...
BACKGROUND: An elevated heart rate is an established marker of cardiovascular risk. Previous analys...
AbstractBackgroundThe aim of this study was to investigate the effect of ivabradine on symptoms, qua...
Background Chronic heart failure is associated with high mortality and morbidity. Raised resting hea...
Chronic heart failure is associated with high mortality and morbidity. Raised resting heart rate is ...